ARCHIVES

DCT Board Approves Proposals For Increased Efforts With Biological Response Modifiers, Oks Contracts

This article is from The Cancer Letter archive.

Vol. 05 No. 45 | November 9, 1979

Download PDF Visit The Full Archive

Related Articles

Natcher: Multiple Year Funding Would Not be Approved If Presented As Request For Reprogramming

March 22, 1985

Gleevec First Pediatric Cancer Approval By FDA In 13 Years

May 30, 2003

Dendritic Cell Vaccine Increases PFS in Phase II Clinical Trial

December 27, 2013

Senate Committee Blocks Effort To Overturn Organ Systems Changes

December 10, 1982

In Brief: Boutwell Declines Nomination to New NCAB Term; Rowley Again Urges Appointment Of Scientists

January 20, 1984

Reinventing NCI: Clinical Trials System Changes Not Easy Or Quick, Klausner Says; NCAB Members, Others, Sound Off On Group’s Report

October 10, 1997